高级检索
当前位置: 首页 > 详情页

Individual and Combined Cardiometabolic Morbidities and the Subsequent Risk of Cardiovascular Events in Chinese Adults

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Zhengzhou Univ, Dept Internal Med, Div Endocrinol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China [2]Fujian Med Univ, Fujian Prov Hosp, Fuzhou, Peoples R China [3]Luzhou Med Coll, Affiliated Hosp, Luzhou, Peoples R China [4]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China [5]First Hosp Jilin Univ, Changchun, Peoples R China [6]Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China [7]First Hosp Lanzhou Univ, Lanzhou, Peoples R China [8]Nanchang Univ, Jiangxi Prov Peoples Hosp, Nanchang, Jiangxi, Peoples R China [9]Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Peoples R China [10]Guiyang Med Coll, Affiliated Hosp, Guiyang, Peoples R China [11]Dalian Municipal Cent Hosp, Dalian, Peoples R China [12]Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Shanghai, Peoples R China [13]Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China [14]Shandong Univ, Shandong Prov Hosp, Jinan, Peoples R China [15]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China [16]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China [17]Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China [18]Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China [19]Shandong Univ, Qilu Hosp, Jinan, Peoples R China [20]Cent Hosp Shanghai Jiading Dist, Shanghai, Peoples R China [21]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China [22]Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China [23]Jiangsu Prov Hosp Integrat Chinese & Western Med, Nanjing, Peoples R China [24]Karamay Municipal Peoples Hosp, Karamay, Xinjiang, Peoples R China [25]Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China [26]Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med,Dept Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Shanghai, Peoples R China [27]Shanghai Jiao Tong Univ, Shanghai Natl Clin Res Ctr Metab Dis, Key Lab Endocrine & Metab Dis,Ruijin Hosp,Sch Med, Natl Hlth Commiss PR China,Shanghai Natl Ctr Tran, Shanghai, Peoples R China
出处:
ISSN:

关键词: Diabetes hypertension dyslipidemia combined cardiometabolic morbidities cardiovascular events

摘要:
Context Diabetes, hypertension and dyslipidemia accelerates the incidence of cardiovascular disease (CVD) events. However, data regarding the association between main cardiometabolic morbidities such as diabetes, hypertension, and dyslipidemia and the subsequent risk of CVD events in Chinese adults are still limited. Objective To investigate the associations between individual and combined cardiometabolic morbidities and incident cardiovascular events in Chinese adults. Methods Baseline data were obtained from a prospective, nationwide, and population-based cohort study in China during 2011-2012. A total of 133 572 participants aged >= 40 years were included in the study. The main outcome measures were CVD events. Results Compared with participants without diabetes, hypertension and dyslipidemia, participants with only diabetes (hazard ratio [HR], 1.58; 95% CI, 1.32-1.90) or only hypertension (2.04; 1.82-2.28) exhibited significantly higher risk for CVD events, while participants with only dyslipidemia (0.97; 0.84-1.12) exhibited no significantly higher risk for CVD events. When analyzed collectively, participants with diabetes plus hypertension (HR, 2.67; 95% CI, 2.33-3.06), diabetes plus dyslipidemia (1.57; 1.32-1.87), and hypertension plus dyslipidemia (2.12; 1.88-2.39) exhibited significantly higher risk for CVD. Moreover, participants with the combination of diabetes, hypertension, and dyslipidemia exhibited the highest risk for CVD events (HR, 3.06; 95% CI, 2.71-3.46). Multivariable-adjusted HRs (95% CIs) for CVD associated with diabetes based on fasting glucose >= 7.0 mmol/L, oral glucose tolerance test 2-hour glucose >= 11.1 mmol/L, and hemoglobin A1c >= 6.5% were 1.64 (1.51-1.78), 1.57 (1.45-1.69), and 1.54 (1.42-1.66), respectively; associated with hypertension based on systolic blood pressure >= 140 mmHg and diastolic blood pressure >= 90 mmHg were 1.89 (1.76-2.03) and 1.74 (1.60-1.88), respectively; associated with dyslipidemia based on total cholesterol >= 6.22 mmol/L, low-density lipoprotein cholesterol >= 4.14 mmol/L, high-density lipoprotein cholesterol <1.04 mmol/L, and triglycerides >= 2.26 mmol/L were 1.18 (1.08-1.30), 1.30 (1.17-1.44), 1.00 (0.92-1.09), and 1.10 (1.01-1.20), respectively. Conclusion Diabetes, hypertension and dyslipidemia showed additive associations with the risk of CVD events in middle-aged and elderly Chinese adults.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 医学
小类 | 2 区 内分泌学与代谢
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 内分泌学与代谢
JCR分区:
出版当年[2020]版:
Q1 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q1 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Zhengzhou Univ, Dept Internal Med, Div Endocrinol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:0 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)